News
The FDA has endorsed ZYN products for sale as a harm reduction measure to help smokers quit. Nonetheless, rising ZYN usage ...
Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's approval noted the patches posed ...
StockStory.org on MSN14h
Altria (MO): Buy, Sell, or Hold Post Q1 Earnings?Altria has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.5%. The stock now trades ...
17h
The Punch on MSNCAPPA urges tobacco-style warning labels on sugary drinksThe Corporate Accountability and Public Participation Africa has called on the Federal Government to mandate sugar-sweetened beverage manufacturers to place front-of-pack warning labels on their ...
Vaping, Juuling, cloud chasing – we have all most likely heard of electronic cigarettes or vapes. With so many new terms and devices being pushed to market, it can feel hard to keep track of the ...
Philip Morris International's U.S. business, PMI U.S., unveiled its new "Invested in America" advertising campaign, ...
Oral nicotine pouches—small, smokeless, nearly invisible and placed between the lip and gum—are rapidly gaining popularity ...
Philip Morris is growing its alternative products rapidly, seeing strong revenue and gross profit tailwinds, driven by volume ...
MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...
The big reason to buy Altria's ( MO 1.65%) stock is its lofty 6.9% dividend yield. For comparison, stocks in the S&P 500 are ...
MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future ...
One University of Iowa researcher believes the penalties aren’t harsh enough. Doctor Anthony Fischer led a study that found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results